MichaelAlexPapagikosMD

Radiation Oncology • Wilmington, NC

Urologic Cancer

Physician

Join to view full profile

Dr. Papagikos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Papagikos' full profile

Already have an account?

Office
1988 S 16th St
Wilmington, NC 28401
Phone+1 910-251-1839

Fax+1 910-251-8286
Is this information wrong?

Education & Training

Wake Forest University School of MedicineResidency, Radiation Oncology, 2002 - 2006
Yale-New Haven Medical CenterInternship, Transitional Year, 2001 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2001

Certifications & Licensure

NC State Medical License 2002 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 3
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Jun 01
Completed
Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Start of enrollment: 2011 May 01
Active, not recruiting
Phase 3
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2011 Jul 01
Active, not recruiting
Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
Completed
Join now to see all

Publications & Presentations

PubMed

2 citations
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinic...
Jeff M Michalski, Kathryn A Winter, Bradley R Prestidge, Martin G Sanda, Mahul Amin, William S Bice, Hiram A Gay, Geoffrey S Ibbott, Juanita M Crook, Charles N Catton,...> ;Journal of Clinical Oncology. 2023 Aug 20
3 citations
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/R...
Benjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, Alvaro A Martinez, Gerard C Morton, Daniel J Krauss, Di Yan, Deborah E Citrin, Bruce W Hershatter, Jeff M Michal...> ;Journal of Clinical Oncology. 2023 Jun 10
1 citations
Carolina Hurricanes.
Trevor J Royce, Michael A Papagikos, Lawrence B Marks, Maguire, P.> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Mar 1
12 citations
Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study.
Jordan A. Holmes, Roger F. Anderson, Leroy G. Hoffman, Timothy N. Showalter, Mohit Kasibhatla, Sean P. Collins, Michael A. Papagikos, Brittany D. Barbosa, Kristy Allig...> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Jan 1
39 citations
Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer.
W. Jeffrey Petty, James J. Urbanic, Tamjeed Ahmed, R.T. Hughes, Beverly J. Levine, Kyle E. Rusthoven, Michael A. Papagikos, Jimmy Ruiz, Brian E. Lally, Michael D. Chan...> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Nov 1
24 citations
Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer
Matthew J. Boyer, Michael A. Papagikos, Rex Kiteley, Zeljko Vujaskovic, J. Wu, W. Robert Lee> ;Radiation Oncology. 2017 Jan 13
140 citations
Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial
Renato G. Martins, Upendra Parvathaneni, Julie E. Bauman, Anand K. Sharma, Luis E. Raez, Michael A. Papagikos, Furhan Yunus, Brenda F. Kurland, Keith D. Eaton, Jay J. ...> ;Journal of Clinical Oncology. 2013 Apr 10
31 citations
Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer
Patrick D. Maguire, Michael A. Papagikos, Sue Hamann, Charles R. Neal, M.B. Meyerson, Neil Hayes, Peter Ungaro, Kenneth Kotz, Marion E. Couch, Hoke Pollock, Joel E. Te...> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Mar 15
3 citations
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
Michael A. Papagikos, Peter J. Rossi, James J. Urbanic, Allan F. deGuzman, David L. McCullough, Peter E. Clark, W. Robert Lee> ;American Journal of Clinical Oncology. 2007 Apr 1
Commentary (Papagikos/Lee): Permanent Prostate Brachytherapy.
Michael A. Papagikos, W. Robert Lee, MEd> ;Oncology. 2006 Apr 17
90 citations
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Arash J. Gabayan, Sylvan B. Green, Abhay Sanan, Joseph M. Jenrette, Christopher J. Schultz, Michael A. Papagikos, Stephen P. Tatter, Ashish Patel, Pradip Amin, Robert ...> ;Neurosurgery. 2006 Apr 1
14 citations
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate ...
Peter J. Rossi, Peter E. Clark, Michael A. Papagikos, David L. McCullough, W. Robert Lee> ;Urology. 2006 Feb 1
22 citations
Lessons learned from randomised clinical trials in adult low grade glioma
Michael A. Papagikos, Edward G. Shaw, Volker W. Stieber> ;The Lancet. Oncology. 2005 Apr 1
44 citations
Dosimetric Quantifiers for Low Dose Rate Prostate Brachytherapy: V100 Is Superior to D90
Michael A. Papagikos, Allan F. deGuzman, Peter J. Rossi, David L. McCullough, Peter E. Clark, W.R. Lee> ;Brachytherapy. 2005 Jan 1
21 citations
Publication rate of abstracts from the annual ASTRO meeting: Comparison with other organizations
Michael A. Papagikos, Peter J. Rossi, W. Robert Lee> ;Journal of the American College of Radiology. 2005 Jan 1
45 citations
Chemoradiation for adenocarcinoma of the anus.
Michael A. Papagikos, Christopher H. Crane, John M. Skibber, Nora A. Janjan, Barry W. Feig, Miguel A. Rodriguez-Bigas, Arthur Y. Hung, Robert A. Wolff, Marc E. Delclos...> ;International Journal of Radiation Oncology, Biology, Physics. 2003 Mar 1
Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
Crane, C. H., Antolak, J. A., Rosen, I. I., Forster, K. M., Evans, D. B., Janjan, N. A., Charnsangavej, C., Pisters, P. W., Lenzi, R., Papagikos, M. A., Wolff, R. A.> ;Int J Gastrointest Cancer. 2001
Gamma knife radiosurgery treatment planning for small animals using high-resolution 7T micro-magnetic resonance imaging.
Wiant, D., Atwood, T. F., Olson, J., Papagikos, M., Forbes, M. E., Riddle, D. R., Bourland, J. D.> ;Radiat Res. 2009 Nov 01
Join now to see all

Press Mentions

American Cancer Society Honors Novant Health, New Hanover Regional Medical Center with National AwardMarch 15th, 2022
Coastal Carolina Radiation Oncology and New Hanover Regional Medical Center-Radiation Oncology Adopt MIM Software as Provider of Standardization PlatformJune 4th, 2019
Novant NHRMC Expands Clinical TrialsAugust 9th, 2023